Search Results - "церебральная микроангиопатия"

1

Academic Journal

Periventricular leukomalacia - the clinical-imaging challenge. A narrative review ; LEUCOMALACIA PERIVENTRICULARĂ - PROVOCARE CLINICO-IMAGISTICĂ. REVISTA LITERATURII ; Перивентрикулярная лейкомаляция-клинико-визуализационные аспекты. Обзор литературы

Authors: DONCA, Catalina, BÎLHAC , Zinaida, PLESHCAN, Tatiana, SANGHELI, Marina

Source: Bulletin of the Academy of Sciences of Moldova. Medical Sciences; Vol. 80 No. 3 (2024): Medical Sciences; 34-40 ; Buletinul Academiei de Științe a Moldovei. Științe medicale; Vol. 80 Nr. 3 (2024): Ştiinţe medicale; 34-40 ; Вестник Академии Наук Молдовы. Медицина; Том 80 № 3 (2024): Медицина; 34-40 ; 1857-0011

Subject Terms: перивентрикулярная лейкомаляция, магнитно-резонансная томография, рассеянный склероз, церебральная микроангиопатия, дифференциальный диагноз, leucomalacie periventriculară, imagerie prin rezonanță magnetică, scleroză multiplă, microangiopatie cerebrală, diagnostic diferențial, periventricular leu komalacia, magnetic resonance imaging, multiple sclerosis, cerebral microangiopathy, differential diagnosis

File Description: application/pdf

Relation: https://bulmed.md/bulmed/article/view/3716/3707; https://bulmed.md/bulmed/article/view/3716

Availability: https://bulmed.md/bulmed/article/view/3716
https://doi.org/10.52692/1857-0011.2024.3-80.06

View record from BASE

2

Academic Journal

Leucomalacia periventriculară ndash; provocare clinico- imagistică. Revista literaturii

Authors: Donică Cauş, C., Caus, C., Bîlhac, Z., Pleşcan, T., Sangheli, M.M.

Source: Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale 80 (3) 34-40

Subject Terms: магнитно-резонансная томография, дифференциальный диагноз, periventricular leu komalacia, diagnostic diferenţial, перивентрикулярная лейкомаляция, церебральная микроангиопатия, multiple sclerosis, рассеянныйсклероз, leucomalacie periventriculară, microangiopatiecerebrală, differential diagnosis, scleroza multiplă, magnetic resonance imaging, imagerie prin rezonanță magnetică, cerebral microangiopathy

File Description: application/pdf

Access URL: https://ibn.idsi.md/vizualizare_articol/220183

View record at OpenAIRE

3

Academic Journal

Impact of endothelial inflammation on depression in patients with cerebral microangiopathy: a prospective study ; Влияние эндотелиального воспаления на депрессию у пациентов с церебральной микроангиопатией: проспективное исследование

Authors: O. V. Vorobyeva, A. A. Pilipovich, V. V. Fateeva, О. В. Воробьева, А. А. Пилипович, В. В. Фатеева

Source: Neurology, Neuropsychiatry, Psychosomatics; Vol 14, No 1 (2022); 32-37 ; Неврология, нейропсихиатрия, психосоматика; Vol 14, No 1 (2022); 32-37 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2022-1

Subject Terms: церебральная микроангиопатия, inflammatory markers, depression, cerebral microangiopathy, маркеры воспаления, депрессия

File Description: application/pdf

Relation: https://nnp.ima-press.net/nnp/article/view/1745/1366; World Health Organization, Depression, Fact Sheet, 2017 (updated May 2019). Available from: http://www.who.int/mediacentre/factsheets/fs369/en/; Sassarini DJ. Depression in midlife women. Maturitas. 2016 Dec;94:149-54. doi:10.1016/j.maturitas.2016.09.004. Epub 2016 Sep 16.; Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010 Mar 1;67(5):446-57. doi:10.1016/j.biopsych.2009.09.033. Epub 2009 Dec 16.; Yu RH, Ho SC, Lam CW, et al. Psychological factors and subclinical atherosclerosis in postmenopausal Chinese women in Hong Kong. Maturitas. 2010 Oct;67(2):186- 91. doi:10.1016/j.maturitas.2010.06.014. Epub 2010 Jul 17.; Chrysohoou C, Kollia N, Tousoulis D. The link between depression and atherosclerosis through the pathways of inflammation and endothelium dysfunction. Maturitas. 2018 Mar;109:1-5. doi:10.1016/j.maturitas.2017.12.001. Epub 2017 Dec 6.; Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146,538 participants in 54 observational studies. Eur Heart J. 2006 Dec;27(23):2763-74. doi:10.1093/eurheartj/ehl338. Epub 2006 Nov 2.; Kyrou I, Kollia N, Panagiotakos D, et al; ATTICA Study Investigators, Association of depression and anxiety status with 10-year cardiovascular disease incidence among apparently healthy Greek adults: the ATTICA study. Eur J Prev Cardiol. 2017 Jan;24(2):145-52. doi:10.1177/2047487316670918. Epub 2016 Sep 27.; Wardlaw JM, Smith EE, Biessels GJ. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013 Aug;12(8):822-38. doi:10.1016/S1474- 4422(13)70124-8; Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology. 2000 Apr;22(4):370-9. doi:10.1016/S0893-133X(99)00134-7; Maes M. Cytokines in major depression. Biol Psychiatry. 1994 Oct 1;36(7):498-9. doi:10.1016/0006-3223(94)90652-1; Jokela M, Virtanen M, Batty GD, Kivimaki M. Inflammation and specific symptoms of depression. JAMA Psychiatry. 2016 Jan;73(1):87-8. doi:10.1001/jamapsychiatry.2015.1977; Frasure-Smith N, Lesperance F, Irwin MR. Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes. Biol Psychiatry. 2007 Aug 15;62(4):302-8. doi:10.1016/j.biopsych.2006.09.029. Epub 2007 Jan 8.; Copeland WE, Shanahan L, Worthman C. Cumulative depression episodes predict later C-reactive protein levels: a prospective analysis. Biol Psychiatry. 2012 Jan 1;71(1):15-21. doi:10.1016/j.biopsych.2011.09.023. Epub 2011 Nov 1.; Wium-Andersen MK, ∅rsted DD, Nielsen SF. Elevated C-reactive protein levels, psychological distress, and depression in 73 131 Individuals. JAMA Psychiatry. 2013 Feb;70(2):176-84. doi:10.1001/2013.jamapsychiatry.102; Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-a, and IL-6: a meta-analysis. Psychosom Med. 2009 Feb;71(2):171-86. doi:10.1097/PSY.0b013e3181907c1b. Epub 2009 Feb 2.; Hamer M, Batty GD, Marmot MG. Anti-depressant medication use and C-reactive protein: results from two population-based studies. Brain Behav Immun. 2011 Jan;25(1):168-73. doi:10.1016/j.bbi.2010.09.013. Epub 2010 Sep 21.; Setiawan E, Wilson AA, Mizrahi R, et al. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry. 2015 Mar;72(3):268-75. doi:10.1001/jamapsychiatry.2014.2427; Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004 Jun 15;109(23 Suppl 1):III27-32. doi:10.1161/01.CIR.0000131515.03336.f8; Verma S, Buchanan MR, Anderson TJ. Endothelial function testing as a biomarker of vascular disease. Circulation. 2003 Oct 28;108(17):2054-9. doi:10.1161/01.CIR.0000089191.72957.ED; Rybakowski JK, Wykretowicz A, Heymann-Szlachcinska A, Wysocki H. Impairment of endothelial function in unipolar and bipolar depression. Biol Psychiatry. 2006 Oct 15;60(8):889-91. doi:10.1016/j.biopsych.2006.03.025. Epub 2006 May 30.; Broadley AJ, Korszun A, Jones CJ, Frenneaux MP. Arterial endothelial function is impaired in treated depression. Heart. 2002 Nov;88(5):521-3. doi:10.1136/heart.88.5.521

Availability: https://nnp.ima-press.net/nnp/article/view/1745
https://doi.org/10.14412/2074-2711-2022-1-32-37

View record from BASE

4

Academic Journal

MRI in the Assessment of Cerebral Small Vessel Disease: МРТ в оценке прогрессирования церебральной микроангиопатии

Authors: V Gnedovskaya Elena, Anastasiya N. Sergeeva, Larisa A. Dobrynina, N Sergeeva Anastasiya, M V Krotenkova, Elena V. Gnedovskaya, V Krotenkova Marina, A Dobrynina Larisa

Source: Анналы клинической и экспериментальной неврологии, Vol 12, Iss 1, Pp 61-68 (2018)

Subject Terms: microbleed, 03 medical and health sciences, 0302 clinical medicine, cerebral small vessel disease, white matter hyperintensity, церебральная микроангиопатия, болезнь малых сосудов, гиперинтенсивность белого вещества, лакунарные инфаркты, микрокровоизлияния, периваскулярные пространства, lacunar stroke, Neurosciences. Biological psychiatry. Neuropsychiatry, perivascular spaces, RC321-571, 3. Good health

Access URL: https://doaj.org/article/a8c4d4a4ecc242479227af6bd38c2494
https://annaly-nevrologii.com/journal/pathID/article/view/515
https://annaly-nevrologii.com/journal/pathID/article/download/515/406

View record at OpenAIRE

5

Academic Journal

Management tactics in patients with chronic cerebral ischemia during COVID-19 pandemic ; Особенности ведения пациентов с хронической ишемией головного мозга в период пандемии COVID-19

Authors: A. A. Kulesh, А. А. Кулеш

Source: Neurology, Neuropsychiatry, Psychosomatics; Vol 13, No 3 (2021); 4-11 ; Неврология, нейропсихиатрия, психосоматика; Vol 13, No 3 (2021); 4-11 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2021-3

Subject Terms: дипиридамол, cerebral microangiopathy, lacunar stroke, COVID-19, dipyridamole, церебральная микроангиопатия, лакунарный инсульт

File Description: application/pdf

Relation: https://nnp.ima-press.net/nnp/article/view/1567/1241; https://nnp.ima-press.net/nnp/article/view/1567/1251; Парфенов ВА. Сосудистые когнитивные нарушения и хроническая ишемия головного мозга (дисциркуляторная энцефалопатия). Неврология, нейропсихиатрия, психосоматика. 2019;11(3S):61-7. doi:10.14412/2074-2711-2019-3S-61-67; Кулеш АА, Емелин АЮ, Боголепова АН и др. Клинические проявления и вопросы диагностики хронического цереброваскулярного заболевания (хронической ишемии головного мозга) на ранней (додементной) стадии. Неврология, нейропсихиатрия, психосоматика. 2021;13(1):4-12. doi:10.14412/2074-2711-2021-1-4-12; Iadecola C, Duering M, Hachinski V, et al. Vascular Cognitive Impairment and Dementia: JACC Scientific Expert Panel. J Am Coll Cardiol. 2019 Jul 2;73(25):3326-44. doi:10.1016/j.jacc.2019.04.034; Кулеш АА, Дробаха ВЕ, Шестаков ВВ. Церебральная болезнь мелких сосудов: классификация, клинические проявления, диагностика и особенности лечения. Неврология, нейропсихиатрия, психосоматика. 2019;11(3S):4-17. doi:10.14412/2074-2711-2019-3S-4-17; Dichgans M, Leys D. Vascular Cognitive Impairment. Circ Res. 2017 Feb 3;120(3):573- 91. doi:10.1161/CIRCRESAHA.116.308426; Новосадова ОА, Кулеш АА, Григорьева ВН. Диагностика церебральной амилоидной ангиопатии: на пути к Бостонским критериям 2.0. Российский неврологический журнал. 2020;25(5):4-13.; Данченко ИЮ, Кулеш АА, Дробаха ВЕ и др. Синдром CADASIL: дифференциальная диагностика с рассеянным склерозом. Журнал неврологии и психиатрии им. С.С. Корсакова. 2019;119(10-2):128-36. doi:10.17116/jnevro201911910128; Кулеш АА, Дробаха ВЕ, Шестаков ВВ. Церебральная спорадическая неамилоидная микроангиопатия: патогенез, диагностика и особенности лечебной тактики. Неврология, нейропсихиатрия, психосоматика. 2018;10(4):13-22. doi:10.14412/2074-2711-2018-4-13-22; Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol. 2019;18(7):684-96. doi:10.1016/S1474-4422(19)30079-1; Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration: a united approach. Lancet Neurol. 2013;12:822-38. doi:10.1016/S1474-4422(13)70124-8; Pires PW, Dams Ramos CM, Matin N, Dorrance AM. The effects of hypertension on the cerebral circulation. Am J Physiol Heart Circ Physiol. 2013 Jun 15;304(12):H1598-614. doi:10.1152/ajpheart.00490.2012. Epub 2013 Apr; 12. Hu X, De Silva TM, Chen J, Faraci FM. Cerebral vascular disease and neurovascular injury in ischemic stroke. Circ Res. 2017 Feb 3;120(3):449-71. doi:10.1161/CIRCRESAHA.116.308427; Kelly DM, Rothwell PM. Blood pressure and the brain: the neurology of hypertension. Pract Neurol. 2020 Apr;20(2):100-8. doi:10.1136/practneurol-2019-002269. Epub 2019 Sep 26.; Benetos A, Adamopoulos C, Bureau JM, et al. Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation. 2002 Mar 12;105(10):1202-7. doi:10.1161/hc1002.105135; Webb AJ, Simoni M, Mazzucco S, et al. Increased cerebral arterial pulsatility in patients with leukoaraiosis: arterial stiffness enhances transmission of aortic pulsatility. Stroke. 2012 Oct;43(10):2631-6. doi:10.1161/STROKEAHA.112.655837. Epub 2012 Aug 23.; Rothwell PM, Howard SC, Dolan E, et al.; ASCOT-BPLA and MRC Trial Investigators. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol. 2010 May;9(5):469-80. doi:10.1016/S1474-4422(10)70066-1. Epub 2010 Mar 11.; Iadecola C, Gottesman RF. Neurovascular and Cognitive Dysfunction in Hypertension. Circ Res. 2019 Mar 29;124(7):1025-44. doi:10.1161/CIRCRESAHA.118.313260; Iadecola C. The neurovascular unit coming of age: a journey through neurovascular coupling in health and disease. Neuron. 2017 Sep 27;96(1):17-42. doi:10.1016/j.neuron.2017.07.030; Blanco PJ, Müller LO, Spence JD. Blood pressure gradients in cerebral arteries: a clue to pathogenesis of cerebral small vessel disease. Stroke Vasc Neurol. 2017 Jun 8;2(3):108-17. doi:10.1136/svn-2017-000087. eCollection 2017 Sep.; Brown R, Benveniste H, Black SE, et al. Understanding the role of the perivascular space in cerebral small vessel disease. Cardiovasc Res. 2018 Sep 1;114(11):1462-73. doi:10.1093/cvr/cvy113; Marinkovic S, Milisavljevic M, Puskas L. Microvascular anatomy of the hippocampal formation. Surg Neurol. 1992 May;37(5):339- 49. doi:10.1016/0090-3019(92)90001-4; Wardlaw JM, Makin SJ, Valdes Hernandez MC, et al. Blood-brain barrier failure as a core mechanism in cerebral small vessel disease and dementia: evidence from a cohort study. Alzheimers Dement. 2017;13:634-43. doi:10.1016/j.jalz.2016.09.006; Sam K, Crawley AP, Conklin J, et al. Development of white matter hyperintensity is preceded by reduced cerebrovascular reactivity. Ann Neurol. 2016 Aug;80(2):277-85. doi:10.1002/ana.24712; Shi Y, Thrippleton MJ, Blair GW, et al. Small vessel disease is associated with altered cerebrovascular pulsatility but not resting cerebral blood flow. J Cereb Blood Flow Metab. 2020 Jan;40(1):85-99. doi:10.1177/0271678X18803956. Epub 2018 Oct 8.; De Guio F, Mangin JF, Duering M, et al. White matter edema at the early stage of cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke. 2015 Jan;46(1):258-61. doi:10.1161/STROKEAHA.114.007018. Epub 2014 Nov 4.; Rost NS, Cougo P, Lorenzano S, et al. Diffuse microvascular dysfunction and loss of white matter integrity predict poor outcomes in patients with acute ischemic stroke. J Cereb Blood Flow Metab. 2018 Jan;38(1):75-86. doi:10.1177/0271678X17706449. Epub 2017 May 8.; Peres R, De Guio F, Chabriat H, Jouvent E. Alterations of the cerebral cortex in sporadic small vessel disease: a systematic review of in vivo MRI data. J Cereb Blood Flow Metab. 2016 Apr;36(4):681-95. doi:10.1177/0271678X15625352. Epub 2016 Jan 19.; Lyu F, Wu D, Wei C, Wu A. Vascular cognitive impairment and dementia in type 2 diabetes mellitus: An overview. Life Sci. 2020 Aug 1;254:117771. doi:10.1016/j.lfs.2020.117771. Epub 2020 May 11.; Liu J, Rutten-Jacobs L, Liu M, et al. Causal Impact of Type 2 Diabetes Mellitus on Cerebral Small Vessel Disease: A Mendelian Randomization Analysis. Stroke. 2018 Jun;49(6):1325-31. doi:10.1161/STROKEAHA.117.020536. Epub 2018 Apr 23.; Rensma SP, van Sloten TT, Ding J, et al. Type 2 Diabetes, Change in Depressive Symptoms Over Time, and Cerebral Small Vessel Disease: Longitudinal Data of the AGES-Reykjavik Study. Diabetes Care. 2020 Aug;43(8):1781-7. doi:10.2337/dc19-2437. Epub 2020 Jun 11.; Umemura T, Kawamura T. Retinopathy: A sign of cerebral small vessel disease in diabetes? J Diabetes Investig. 2017 Jul;8(4):428-30. doi:10.1111/jdi.12602. Epub 2017 Jan 17.; Sanahuja J, Alonso N, Diez J, et al. Increased Burden of Cerebral Small Vessel Disease in Patients With Type 2 Diabetes and Retinopathy. Diabetes Care. 2016 Sep;39(9):1614-20. doi:10.2337/dc15-2671. Epub 2016 Jun 8.; Blevins BL, Vinters HV, Love S, et al. Brain arteriolosclerosis. Acta Neuropathol. 2021 Jan;141(1):1-24. doi:10.1007/s00401-020-02235-6. Epub 2020 Oct 24.; Feinkohl I, Janke J, Hadzidiakos D, et al. Associations of the metabolic syndrome and its components with cognitive impairment in older adults. BMC Geriatr. 2019 Mar 7;19(1):77. doi:10.1186/s12877-019-1073-7; Agmon Y, Khandheria BK, Meissner I, et al. Independent association of high blood pressure and aortic atherosclerosis: a population-based study. Circulation. 2000 Oct 24;102(17):2087-93. doi:10.1161/01.cir.102.17.2087; Qureshi AI, Caplan LR. Intracranial atherosclerosis. Lancet. 2014 Mar 15;383(9921):984- 98. doi:10.1016/S0140-6736(13)61088-0. Epub 2013 Sep 2.; Moroni F, Ammirati E, Rocca MA, et al. Cardiovascular disease and brain health: Focus on white matter hyperintensities. Int J Cardiol Heart Vasc. 2018 May 14;19:63-9. doi:10.1016/j.ijcha.2018.04.006. eCollection 2018 Jun.; Galan M, Jimenez-Altayo F. Small Resistance Artery Disease and ACE2 in Hypertension: A New Paradigm in the Context of COVID-19. Front Cardiovasc Med. 2020 Oct 30;7:588692. doi:10.3389/fcvm.2020.588692. eCollection 2020.; Spence JD, de Freitas GR, Pettigrew LC, et al. Mechanisms of Stroke in COVID-19. Cerebrovasc Dis. 2020;49(4):451-8. doi:10.1159/000509581. Epub 2020 Jul 20.; Hess DC, Eldahshan W, Rutkowski E. COVID-19-Related Stroke. Transl Stroke Res. 2020 Jun;11(3):322-5. doi:10.1007/s12975-020-00818-9. Epub 2020 May 7.; Tsivgoulis G, Palaiodimou L, Zand R, et al. COVID-19 and cerebrovascular diseases: a comprehensive overview. Ther Adv Neurol Disord. 2020 Dec 8;13:1756286420978004. doi:10.1177/1756286420978004. eCollection 2020.; Szegedi I, Orban-Kalmandi R, Csiba L, Bagoly Z. Stroke as a Potential Complication of COVID-19-Associated Coagulopathy: A Narrative and Systematic Review of the Literature. J Clin Med. 2020 Sep 28;9(10):3137. doi:10.3390/jcm9103137; Jayarangaiah A, Kariyanna PT, Chen X, et al. COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response. Clin Appl Thromb Hemost. Jan-Dec 2020;26:1076029620943293. doi:10.1177/1076029620943293; Geddings JE, Mackman N. New players in haemostasis and thrombosis. Thromb Haemost. 2014 Apr 1;111(4):570-4. doi:10.1160/TH13-10-0812. Epub 2014 Feb 27.; Fuchs TA, Kremer Hovinga JA, Schatzberg D, et al. Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies. Blood. 2012 Aug 9;120(6):1157-64. doi:10.1182/blood-2012-02-412197. Epub 2012 May 18.; Diaz JA, Fuchs TA, Jackson TO, et al. Plasma DNA is Elevated in Patients with Deep Vein Thrombosis. J Vasc Surg Ven Lymph Dis. 2013 Oct 1;1(4):341-348.e1. doi:10.1016/j.jvsv.2012.12.002; Van Montfoort ML, Stephan F, Lauw MN, et al. Circulating nucleosomes and neutrophil activation as risk factors for deep vein thrombosis. Arterioscler Thromb Vasc Biol. 2013 Jan;33(1):147-51. doi:10.1161/ATVBAHA.112.300498. Epub 2012 Oct 25.; Ali RA, Gandhi AA, Meng H, et al. Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome. Nat Commun. 2019 Apr 23;10(1):1916. doi:10.1038/s41467-019-09801-x; Crippa S, Kägi G, Graf L, et al. Stroke in a young adult with mild COVID-19 suggesting endotheliitis. New Microbes New Infect. 2020 Nov;38:100781. doi:10.1016/j.nmni.2020.100781. Epub 2020 Oct 10.; Keller E, Brandi G, Winklhofer S, et al. Large and Small Cerebral Vessel Involvement in Severe COVID-19: Detailed Clinical Workup of a Case Series. Stroke. 2020 Dec;51(12):3719- 22. doi:10.1161/STROKEAHA.120.031224. Epub 2020 Oct 15.; Rothstein A, Oldridge O, Schwennesen H, et al. Acute Cerebrovascular Events in Hospitalized COVID-19 Patients. Stroke. 2020 Sep;51(9):e219-e222. doi:10.1161/STROKEAHA.120.030995. Epub 2020 Jul 20.; Yaghi S, Ishida K, Torres J, et al. SARSCoV-2 and Stroke in a New York Healthcare System. Stroke. 2020 Jul;51(7):2002-11. doi:10.1161/STROKEAHA.120.030335. Epub 2020 May 20.; Tan YK, Goh C, Leow AST, et al. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature. J Thromb Thrombolysis. 2020 Oct;50(3):587-95. doi:10.1007/s11239-020-02228-y; Vogrig A, Gigli GL, Bna C, Morassi M. Stroke in patients with COVID-19: Clinical and neuroimaging characteristics. Neurosci Lett. 2021 Jan 19;743:135564. doi:10.1016/j.neulet.2020.135564. Epub 2020 Dec 19.; Pellegrini D, Kawakami R, Guagliumi G, et al. Microthrombi as a Major Cause of Cardiac Injury in COVID-19: A Pathologic Study. Circulation. 2021 Mar 9;143(10):1031-42. doi:10.1161/CIRCULATIONAHA.120.051828. Epub 2021 Jan 22.; Bois MC, Boire NA, Layman AJ, et al. COVID-19-Associated Nonocclusive Fibrin Microthrombi in the Heart. Circulation. 2021 Jan 19;143(3):230-43. doi:10.1161/CIRCULATIONAHA.120.050754. Epub 2020 Nov 16.; Zuo Y, Estes SK, Ali RA, et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci Transl Med. 2020 Nov 18;12(570):eabd3876. doi:10.1126/scitranslmed.abd3876. Epub 2020 Nov 2.; Elshereye A, Erdinc B. Multiple Lacunar Cerebral Infarcts as the Initial Presentation of COVID-19. Cureus. 2020 Aug 10;12(8):e9638. doi:10.7759/cureus.9638; Regenhardt RW, Das AS, Ohtomo R, et al. Pathophysiology of Lacunar Stroke: History's Mysteries and Modern Interpretations. J Stroke Cerebrovasc Dis. 2019 Aug;28(8):2079-97. doi:10.1016/j.jstrokecerebrovasdis.2019.05.006. Epub 2019 May 28.; Giacomozzi S, Caso V, Agnelli G, et al. Lacunar stroke syndromes as predictors of lacunar and non-lacunar infarcts on neuroimaging: a hospital-based study. Intern Emerg Med. 2020 Apr;15(3):429-36. doi:10.1007/s11739-019-02193-2. Epub 2019 Sep 18.; Ay H, Benner T, Arsava EM, et al. A computerized algorithm for etiologic classification of ischemic stroke: the Causative Classification of Stroke System. Stroke. 2007 Nov;38(11):2979-84. doi:10.1161/STROKEAHA.107.490896. Epub 2007 Sep 27.; Naganuma M, Inatomi Y, Nakajima M, et al. Is the Occlusion Site of the Lenticulostriate Artery Identified on Admission Related to Clinical Prognosis in Patients with Lacunar Stroke? J Stroke Cerebrovasc Dis. 2018 Jul;27(7):2035-42. doi:10.1016/j.jstrokecerebrovasdis.2018.02.058. Epub 2018 Apr 17.; Kamo H, Miyamoto N, Otani H, et al. The Importance of Combined Antithrombotic Treatment for Capsular Warning Syndrome. J Stroke Cerebrovasc Dis. 2018 Nov;27(11):3095-9. doi:10.1016/j.jstrokecerebrovasdis.2018.06.038. Epub 2018 Aug 2.; Regenhardt RW, Das AS, Lo EH, Caplan LR. Advances in Understanding the Pathophysiology of Lacunar Stroke: A Review. JAMA Neurol. 2018 Oct 1;75(10):1273- 81. doi:10.1001/jamaneurol.2018.1073; Williamson JD, Pajewski NM, Auchus AP, et al., for the SPRINT MIND Investigators for the SPRINT Research Group. Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial. JAMA. 2019 Feb 12;321(6):553-61. doi:10.1001/jama.2018.21442; Tzourio C, Anderson C, Chapman N, et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med. 2003 May 12;163(9):1069-75. doi:10.1001/archinte.163.9.1069; Остроумова ОД, Парфенов ВА, Остроумова ТМ и др. Консенсус экспертов. Влияние антигипертензивной терапии на когнитивные функции. Системные гипертензии. 2021;18(1):5-12. doi:10.26442/2075082X.2021.1.200575; Van der Flier WM, Skoog I, Schneider JA, et al. Vascular cognitive impairment. Nat Rev Dis Primers. 2018 Feb 15;4:18003. doi:10.1038/nrdp.2018.3; Kernan WN, Ovbiagele B, Black HR, et al.; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014 Jul;45(7):2160-236. doi:10.1161/STR.0000000000000024. Epub 2014 May 1.; Fonseca AC, Merwick A, Dennis M, et al. European Stroke Organisation (ESO) guidelines on management of transient ischaemic attack. Eur Stroke J. 2021 Mar;6(1):I-LXII. doi:10.1177/2396987321989865. Epub 2021 Feb 19.; The European Stroke Prevention Study (ESPS). Principal end-points. The ESPS Group. Lancet. 1987 Dec 12;2(8572):1351-4.; Diener HC, Cunha L, Forbes C, et al. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996 Nov;143(1-2):1-13. doi:10.1016/s0022-510x(96)00308-5; Weinberger J. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Curr Cardiol Rep. 2007 Mar;9(1):5-6.; Sacco RL, Diener HC, Yusuf S, et al.; PRoFESS Study Group. Aspirin and extendedrelease dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008 Sep 18;359(12):1238-51. doi:10.1056/NEJMoa0805002. Epub 2008 Aug 27.; Гоголева АГ, Захаров ВВ. Вопросы этиологии, проявлений и терапии хронических цереброваскулярных заболеваний. Неврология, нейропсихиатрия, психосоматика. 2020;12(5):84-91. doi:10.14412/2074-2711- 2020-5-84-91; Kim HH, Liao JK. Translational therapeutics of dipyridamole. Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):s39-42. doi:10.1161/ATVBAHA.107.160226. Epub 2008 Jan 3.; Yip S, Benavente O. Antiplatelet agents for stroke prevention. Neurotherapeutics. 2011 Jul;8(3):475-87. doi:10.1007/s13311-011-0060-2; Balakumar P, Nyo YH, Renushia R, et al. Classical and pleiotropic actions of dipyridamole: Not enough light to illuminate the dark tunnel? Pharmacol Res. 2014 Sep;87:144-50. doi:10.1016/j.phrs.2014.05.008. Epub 2014 May 24.; Liu X, Li Z, Liu S, et al. Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19. Acta Pharm Sin B. 2020 Jul;10(7):1205-15. doi:10.1016/j.apsb.2020.04.008. Epub 2020 Apr 20.; Карева ЕН. Особенности фармакологического действия и применения дипиридамола в профилактике и лечении вирусных инфекций. Consilium Medicum. 2016;18(12):80-7.

Availability: https://nnp.ima-press.net/nnp/article/view/1567
https://doi.org/10.14412/2074-2711-2021-3-4-11

View record from BASE

6

Academic Journal

Cognitive impairment in hypertension ; Когнитивные нарушения при артериальной гипертензии

Authors: Yu. A. Starchina, V. V. Zakharov, Ю. А. Старчина, В. В. Захаров

Contributors: This article has been supported by Kanonfarma prodakshn. The sponsor has participated in the development of the investigation project and supported the investigation program, as well as in the decision to submit the article for publication., Статья спонсируется компанией ЗАО «Канонфарма продакшн». Спонсор участвовал в разработке проекта исследования и поддержке исследовательской программы, а также принятии решения о представлении статьи для публикации.

Source: Neurology, Neuropsychiatry, Psychosomatics; Vol 13, No 1 (2021); 113-118 ; Неврология, нейропсихиатрия, психосоматика; Vol 13, No 1 (2021); 113-118 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2021-1

Subject Terms: антигипертензивная терапия, cerebral microangiopathy, cognitive impairment, dementia, antihypertensive therapy, церебральная микроангиопатия, когнитивные нарушения, деменция

File Description: application/pdf

Relation: https://nnp.ima-press.net/nnp/article/view/1522/1211; Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013 May;12(5):483-97. doi:10.1016/S1474-4422(13)70060-7; O'Brien J, Ames D, Gustafson L, et al., editors. Cerebrovascular disease, cognitive impairment and dementia. Second edition of Cerebrovascular disease and dementia. London: Martin Dunitz; 2004.; Chui H. Dementia due to subcortical ischemic vascular disease. Clin Cornerstone. 2001;3(4):40-51. doi:10.1016/s10983597(01)90047-x; Chan SL, Sweet JG, Cipolla MJ. Treatment for cerebral small vessel disease: effect of relaxin on the function and structure of cerebral parenchymal arterioles during hypertension. FASEB J. 2013 Oct;27(10):3917-27. doi:10.1096/fj.13-230797. Epub 2013 Jun 19.; Mills KT, Bundy JD, Kelly TN, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016 Aug 9;134(6):441-50. doi:10.1161/CIRCULATIONAHA.115.018912; Sierra C, Domenech M, Camafort M, et al. Hypertension and mild cognitive impairment. Curr Hypertens Rep. 2012 Dec;14(6):548-55. doi:10.1007/s11906-012-0315-2; Iadecola C, Gottesman RF. Neurovascular and Cognitive Dysfunction in Hypertension. Circ Res. 2019 Mar 29;124(7):1025-44. doi:10.1161/CIRCRESAHA.118.313260; Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010 Jul;9(7):689-701. doi:10.1016/S14744422(10)70104-6; Van Uden IW, Tuladhar AM, de Laat KF, et al. White matter integrity and depressive symptoms in cerebral small vessel disease: the RUN DMC study. Am J Geriatr Psychiatry. 2015 May;23(5):525-35. doi:10.1016/j.jagp.2014.07.002. Epub 2014 Jul 19.; McCarron MO, Nicoll JA. Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage. Lancet Neurol. 2004 Aug;3(8):484-92. doi:10.1016/S1474-4422(04)00825-7.; Koennecke HC. Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications. Neurology. 2006 Jan 24;66(2):165-71. doi:10.1212/01.wnl.0000194266.55694.1e; Imaoka K, Kobayashi S, Fujihara S, et al. Leukoencephalopathy with cerebral amyloid angiopathy: a semiquantitative and morphometric study. J Neurol. 1999 Aug;246(8):661-6. doi:10.1007/s004150050428; Birns J, Kalra L. Cognitive function and hypertension. J Hum Hypertens. 2009 Feb;23(2):86-96. doi:10.1038/jhh.2008.80. Epub 2008 Jul 24.; Gasecki D, Kwarciany M, Nyka W, et al. Hypertension, brain damage and cognitive decline. Curr Hypertens Rep. 2013 Dec;15(6):547-58. doi:10.1007/s11906-013-0398-4; Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010;341:c3666. doi:10.1136/bmj.c3666; Cacciatore F, Abete P, Ferrara N, et al. The role of blood pressure in cognitive impairment in an elderly population. J Hypertens. 1997 Feb;15(2):135-42. doi:10.1097/00004872199715020-00003; Elias MF, Wolf PA, D'Agostino RB, et al. Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol. 1993 Sep 15;138(6):353-64. doi:10.1093/oxfordjournals.aje.a116868; Launer LJ, Masaki K, Petrovitch H, et al. The association between midlife blood pressure levels and late-life cognitive function. JAMA. 995 Dec 20;274(23):1846-51. doi:10.1001/jama.274.23.1846; Kilander L, Nyman H, Boberg M, et al. Hypertension is related to cognitive impairment; a 20-year follow-up of 999 men. Hypertension. 1998 Mar;31(3):780-6. doi:10.1161/01.hyp.31.3.780; Carmelli D, Swan GE, Reed T, et al. Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins. Neurology. 1998 Jun;50(6):1580-5. doi:10.1212/wnl.50.6.1580; Teles de Menezes S, Giatti L, Campos Brant L, et al. Hypertension, Prehypertension, and Hypertension Control. Association With Decline in Cognitive Performance in the ELSA-Brasil Cohort. Hypertension. 2021;77:672-81. doi:10.1161/HYPERTENSIONAHA.120.16080; Sabayan B, Wijsman L, Foster-Dingley JC, et al. Association of visit-to-visit variability in blood pressure with cognitive function in old age: A prospective cohort study. Brit Med J. 2013 Jul 29;347:f4600. doi:10.1136/bmj.f4600; Rawlings AM, Juraschek SP, Heiss G, et al. Association of orthostatic hypotension with incident dementia, stroke, and cognitive decline. Neurology. 2018 Aug 21;91(8):e759e768. doi:10.1212/WNL.0000000000006027. Epub 2018 Jul 25.; Elliott WJ. Association of higher diastolic blood pressure levels with cognitive impairment. Yearbook Cardiol. 2010;2010:29-30. doi:10.1016/S0145-4145(09)79798-9; Pavlik VN, Hyman DJ, Doody R. Cardiovascular risk factors and cognitive function in adults 30-59 years of age (NHANES III). Neuroepidemiology. 2005;24(1-2):42-50. doi:10.1159/000081049. Epub 2004 Sep 24.; Singh-Manoux A, Marmot M. High blood pressure was associated with cognitive function in middle-age in the Whitehall II study. J Clin Epidemiol. 2005 Dec;58(12):1308-15. doi:10.1016/j.jclinepi.2005.03.016; Reitz C, Tang MX, Manly J, et al. Hypertension and the risk of mild cognitive impairment. Arch Neurol. 2007 Dec;64(12):1734-40. doi:10.1001/archneur.64.12.1734; Morris MC, Scherr PA, Hebert LE, et al. Association between blood pressure and cognitive function in a biracial community population of older persons. Neuroepidemiology. 2002;21(3):123-30. doi:10.1159/000054809; Gottesman RF, Schneider AL, Albert M, et al. Midlife hypertension and 20-year cognitive change: The atherosclerosis risk in communities neurocognitive study. JAMA Neurol. 2014 Oct;71(10):1218-27. doi:10.1001/jamaneurol.2014.1646; Kivipelto M, Helkala EL, Hanninen T, et al. Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology. 2001 Jun 26;56(12):1683-9. doi:10.1212/wnl.56.12.1683; Freitag MH, Peila R, Masaki K, et al. Midlife pulse pressure and incidence of dementia: The honolulu-asia aging stud. Stroke. 2006 Jan;37(1):33-7. doi:10.1161/01.STR.0000196941.58869.2d. Epub 2005 Dec 8.; Gottesman RF, Albert MS, Alonso A, et al. Associations between midlife vascular risk factors and 25-year incident dementia in the atherosclerosis risk in communities (aric) cohort. JAMA Neurol. 2017 Oct 1;74(10):1246-54. doi:10.1001/jamaneurol.2017.1658; Goldstein FC, Levey AI, Steenland NK. High blood pressure and cognitive decline in mild cognitive impairment. J Am Geriatr Soc. 2013 Jan;61(1):67-73. doi:10.1111/jgs.12067. Epub 2013 Jan 10.; Whelton PK, Carey RM, Aronow WS, et al. 2017 Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology / American Heart Association task force on clinical practice guidelines. Hypertension. 2018;71:1269-324. doi:10.1161/HYP.0000000000000066; Старчина ЮА, Парфенов ВА, Чазова ИЕ и др. Когнитивные расстройства у пациентов с артериальной гипертензией. Журнал неврологии и психиатрии им. С.С. Корсакова. 2008;(4):19-23.; Farmer ME, Kittner SJ, Abbott RD, et al. Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance: the Framingham Study. J Clin Epidemiol. 1990;43:475-80. doi:10.1016/08954356(90)90136-D; Forette F, Seux ML, Staessen JA, et al. The prevention of dementia with antihypertensive treatment. New evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med. 2002 Oct 14;162(18):2046-52. doi:10.1001/archinte.162.18.2046; Wei J, Yin X, Liu Q, Tan L. Association between hypertension and cognitive function: A cross-sectional study in people over 45 years old in China. J Clin Hypertens. 2018 Nov;20(11):1575-83. doi:10.1111/jch.13393. Epub 2018 Sep 26.; Glynn RJ, Beckett LA, Hebert LE, et al. Current and remote blood pressure and cognitive decline. JAMA. 1999 Feb 3;281(5):438-45. doi:10.1001/jama.281.5.438; Weidung B, Littbrand H, Nordström P, et al. The association between SBP and mortality risk differs with level of cognitive function in very old individuals. J Hypertens. 2016 Apr;34(4):745-52. doi:10.1097/HJH.0000000000000831; The SPRINT MIND Investigators for the SPRINT Research Group. Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial. JAMA. 2019 Feb 12;321(6):553-61. doi:10.1001/jama.2018.21442; Goldstein FC, Hajjar IM, Dunn CB, et al. The relationship between cognitive functioning and the jnc-8 guidelines for hypertension in older adults. J Gerontol A Biol Sci Med Sci. 2017 Jan;72(1):121-6. doi:10.1093/gerona/glw181. Epub 2016 Sep 27.; Sikaroodi H, Yadegari S, Miri SR. Cognitive impairments in patients with cerebrovascular risk factors: A comparison of mini mental status exam and montreal cognitive assessment. Clin Neurol Neurosurg. 2013 Aug;115(8):1276-80. doi:10.1016/j.clineuro.2012.11.026. Epub 2013 Jan 3.; Захаров ВВ, Вахнина НВ, Парфенов ВА. Когнитивные нарушения и их лечение при артериальной гипертензии. Медицинский Совет. 2017;(1S):6-12. doi:10.21518/2079-701X-2017-0-6-12; Захаров ВВ, Вознесенская ТГ. Нервнопсихические нарушения: диагностические тесты. Москва: МЕДпресс-информ; 2013. 320 с.; Захаров ВВ, Яхно НН. Нарушения памяти. Москва: ГЭОТАР-Мед; 2003. 150 c.; Smith EE, Muzikansky A, McCreary CR, et al. Impaired memory is more closely associated with brain beta-amyloid than leukoaraiosis in hypertensive patients with cognitive symptoms. PLoS One. 2018 Jan 30;13(1):e0191345. doi:10.1371/journal.pone.0191345. eCollection 2018.; Tadic M, Cuspidi C, Hering D. Hypertension and cognitive dysfunction in elderly: blood pressure management for this global burden. BMC Cardiovasc Dis. 2016 Nov 3;16(1):208. doi:10.1186/s12872-016-0386-0; McGuinness B, Todd S, Passmore P, et al. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev. 2009;4:CD004034. doi:10.1002/14651858.CD004034.pub3; Tzourio C, Anderson C, Chapman N, et al. PROGRESS Collaborative Group. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med. 2003;163(9):1069-75. doi:10.1001/archinte.163.9.1069; Coca A, Monteagudo E, Domenech M, et al. Can the treatment of hypertension in the middle-aged prevent dementia in the elderly? High Blood Press Cardiovasc Prev. 2016 Jun;23(2):97-104. doi:10.1007/s40292-0160144-5. Epub 2016 Apr 13.; Levi Marpillat N, Macquin-Mavier I, Tropeano AI, et al. Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis. J Hypertens. 2013 Jun;31(6):1073-82. doi:10.1097/HJH.0b013e3283603f53; Ngandu T, Lehtisalo J, Solomon A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385:2255-63.; Яхно НН, Захаров ВВ, Локшина АБ и др. Деменции: Руководство для врачей. Москва: МЕДпресс-информ; 2010. 272 с.; Гаврилова СИ. Фармакотерапия болезни Альцгеймера. Москва: Пульс; 2003. 319 с.; Bonfoco E, Krainc D, Ankarcrona M, et al. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA. 1995 Aug 1;92(16):7162-6. doi:10.1073/pnas.92.16.7162; Reisberg B, Doody R, StЪffler A, et al. Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med. 2003 Apr 3;348(14):1333-41. doi:10.1056/NEJMoa013128; Van Dyck CH, Schmitt FA, Olin JT. A responder analysis of memantine treatment in patients with Alzheimer's disease maintained on donepezil. Am J Geriatr Psychiatry. 2006 May;14(5):428-37. doi:10.1097/01.JGP.0000203151.17311.38; Wilcock GK, Ballard CG, Cooper JA, et al. Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies. J Clin Psychiatry. 2008 Mar;69(3):341-8. doi:10.4088/jcp.v69n0302; Russ TC. Cholinesterase Inhibitors Should Not Be Prescribed for Mild Cognitive Impairment. Evid Based Med. 2014 Jun;19(3):101. doi:10.1136/eb-2013-101687. Epub 2014 Jan 30.; Захаров ВВ. Применение Винпотропила при дисциркуляторной энцефалопатии с недементными когнитивными нарушениями. Журнал неврологии и психиатрии им. С.С. Корсакова. 2010;110(11):13-6.; Лагунин АА. Отчет по синергичному действию винпоцетина и пирацетама в составе комбинированного препарата Винпотропил (Канонфарма продакшн, Россия).; Tayebati S, Di Tullio M, Tomassoni D, et al. Neuroprotective effect of treatment with galantamine and choline alphoscerate on brain microanatomy in spontaneously hypertensive rats. J Neurol Sci. 2009 Aug 15;283(1-2):187-94. doi:10.1016/j.jns.2009.02.349. Epub 2009 Mar 21.; Камчатнов ПР, Евзельман МА, Морозова ЮА. Возможности комбинированной терапии пациентов с хроническими расстройствами мозгового кровообращения. Поликлиника. 2017;(2):73-8.

Availability: https://nnp.ima-press.net/nnp/article/view/1522
https://doi.org/10.14412/2074-2711-2021-1-113-118

View record from BASE

7

Academic Journal

Comparative study of pharmacological correction strategies for moderate cognitive impairment in hypertensive patients ; Сравнительное исследование стратегий фармакологической коррекции умеренных когнитивных нарушений у больных, страдающих артериальной гипертензией

Authors: O. V. Vorobyeva, Zh. M. Sizova, L. M. Bogatyreva, О. В. Воробьева, Ж. М. Сизова, Л. М. Богатырева

Contributors: Публикация статьи поддержана АО «Сервье»

Source: Neurology, Neuropsychiatry, Psychosomatics; Vol 11, No 2 (2019); 52-59 ; Неврология, нейропсихиатрия, психосоматика; Vol 11, No 2 (2019); 52-59 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2019-2

Subject Terms: пирибедил, cerebral microangiopathy, moderate cognitive impairment, piribedil, церебральная микроангиопатия, умеренные когнитивные нарушения

File Description: application/pdf

Relation: https://nnp.ima-press.net/nnp/article/view/1100/878; Di Bari M, Pahor M, Franse LV, et al. Dementia and disability outcomes in large hypertension trials: lessons learned from the Systolic Hypertension in the Elderly Program (SHEP) trial. Am J Epidemiol. 2001 Jan 1; 153(1):72-8.; Petrovitch H, White LR, Izmirilian G, et al. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging Study. Neurobiol Aging. 2000 Jan-Feb;21(1):57-62.; Forette F, Seux ML, Staessen JA, et al. Prevention of dementia in randomized doubleblind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998 Oct 24; 352(9137):1347-51.; Iadecola C, Yaffe K, Biller J, et al. Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association. Hypertension. 2016 Dec;68(6):e67-e94. Epub 2016 Oct 10.; Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol. 1987 Aug;149(2):351-6.; Захаров ВВ. Всероссийская программа исследований эпидемиологии и терапии когнитивных расстройств в пожилом возрасте («Прометей»). Неврологический журнал. 2006;11(2):27–32.; Elias PK, Elias MF, Robbins MA, Budge MM. Blood pressure-related cognitive decline: does age make a difference? Hypertension. 2004 Nov; 44(5):631-6. Epub 2004 Oct 4.; Levine DA, Galecki AT, Langa KM, et al. Blood Pressure and Cognitive Decline Over 8 Years in Middle-Aged and Older Black and White Americans. Hypertension. 2019 Feb; 73(2):310-318. doi:10.1161/HYPERTENSIONAHA.118.12062.; Li XF, Cui LM, Sun DK, et al. The correlation between cognitive impairment and ambulatory blood pressure in patients with cerebral small vessel disease. Eur Rev Med Pharmacol Sci. 2017 Jul;21(3 Suppl):52-56.; Nagaraja D, Jayashree S. Randomized study of the dopamine receptor agonist piribedil in the treatment of mild cognitive impairment. Am J Psychiatry. 2001 Sep;158(9):1517-9.; Яхно НН, Захаров ВВ, Страчунская ЕЯ и др. Лечение недементных когнитивных нарушений у пациентов с артериальной гипертензией и церебральным атеросклерозом (По данным российского мультицентрового исследования «ФУЭТЕ»). Неврологический журнал. 2012;17(4):49-55.

Availability: https://nnp.ima-press.net/nnp/article/view/1100
https://doi.org/10.14412/2074-2711-2019-2-52-59

View record from BASE

8

Academic Journal